✦ LIBER ✦

Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial

✍ Scribed by Lomax, Anna J.; Yee Yap, Saw; White, Karen; Beith, Jane; Abdi, Ehtesham; Broad, Adam; Sewak, Sanjeev; Lee, Chooi; Sambrook, Philip; Pocock, Nicholas; Henry, Margaret J.; Yeow, Elaine G.; Bell, Richard

Book ID: 122148861
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 789 KB
Volume: 2
Category: Article
ISSN: 2212-1374
DOI: 10.1016/j.jbo.2013.08.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2007 POSTER Recommendations for the prev

2007 POSTER Recommendations for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer

✍ M.S. Aapro; P. Hadji; A. Brufsky; M. Tubiana-Hulin; T. Guise; J.J. Body 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Guidance for the prevention of bone loss

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

✍ R. Rizzoli, J. J. Body, A. De Censi, J. Y. Reginster, P. Piscitelli, M. L. Brand 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Erratum to: Guidance for the prevention

Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

✍ R. Rizzoli, J. J. Body, A. DeCensi, J. Y. Reginster, P. Piscitelli, M. L. Brandi 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 54 KB

Zoledronic acid (ZA) prevents aromatase

Zoledronic acid (ZA) prevents aromatase inhibitor (Al)-associated bone loss in postmenopausal women with early breast cancer -36-month follow-up of the Z-FAST study

✍ A. Brufskv; L. Bosserman; R. Caradonna; B. Haley; M. Jones; H. Moore; M. Dong; G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Immediate Administration of Zoledronic A

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

✍ Antonio Llombart; Antonio Frassoldati; Outi Paija; Harm Peter Sleeboom; Guy Jeru 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 437 KB

Zoledronic Acid Effectively Prevents Aro

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

✍ Adam M. Brufsky; Linda D. Bosserman; Richard R. Caradonna; Barbara B. Haley; C. 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 151 KB